drugset / Trial / NCT03767569

Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients

NCT03767569

Phase 3 Unknown 134 enrolled University Hospital Brussels
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A randomized controlled trial to evaluate whether pretreatment with myo-inositol can lower testosterone levels and improve clinical outcomes in hyperandrogenic PCOS patients undergoing ART

Timeline

Start
2018-09-01
Primary completion
2020-04
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Inositol Small molecule 4 mg
Subject folic acid Other / unclassified 0.4 mg